SHH · 605177.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Zhejiang East Asia Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 25.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Zhejiang East Asia Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.33 per share, paid annual. The forward yield is 1.55% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Zhejiang East Asia Pharmaceutical Co., Ltd.’s next earnings report is currently expected on Oct 31, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zhejiang East Asia Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Founded in 1992, Zhejiang East Asia Pharmaceutical Co., Ltd. operates in the manufacture and supply of active pharmaceutical ingredients (APIs), tablets, granules, and capsules. The company's principal office is situated in Taizhou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:43 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥314.79M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥27.45-CN¥0.46 (-1.65%)
Zhejiang Wecome Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 31.75% below the high.
CN¥3.08-CN¥0.11 (-3.45%)
Jiangsu Sihuan Bioengineering Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
CN¥23.96-CN¥0.88 (-3.54%)
Hubei Goto Biopharm Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.46% below the high.
CN¥11.00-CN¥0.80 (-6.78%)
Shandong Sito Bio-technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.39% below the high.
CN¥5.96-CN¥0.09 (-1.49%)
Jilin Jian Yisheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.43% below the high.
CN¥7.37-CN¥0.15 (-1.99%)
Guiyang Xintian Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.7% below the high.
CN¥5.34-CN¥0.13 (-2.38%)
Tiansheng Pharmaceutical Group Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 14.97% below the high.
CN¥11.85-CN¥0.56 (-4.51%)
Jiangsu gdk Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 62.02% below the high.
